Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCXELTI
Stock Latest News
Private Companies
Xeltis Steps Up European aXess Commercialization and Clinical Outreach as Innovation Profile Rises
43m ago
XELTI
Premium
Private Companies
Xeltis Highlights aXess Momentum and Clinical Engagement in Vascular Access
2d ago
XELTI
Premium
Private Companies
Xeltis Gains Innovation Award as Commercial Push for aXess Vascular Access Implant Accelerates
7d ago
XELTI
Premium
Private Companies
Innovation Award and EIB Summit Exposure Highlight Xeltis’s Vascular Access Focus
9d ago
XELTI
Premium
Private Companies
Xeltis Strengthens Commercial Leadership Ahead of U.S. Market Expansion
11d ago
XELTI
Premium
Private Companies
Xeltis – Weekly Recap
14d ago
XELTI
Premium
Private Companies
Xeltis Highlights European Commercial Availability of aXess Vascular Implant
15d ago
XELTI
Premium
Private Companies
Xeltis Leadership Highlights European Commercialization Progress for aXess Vascular Platform
16d ago
XELTI
Premium
Private Companies
Xeltis Highlights Vascular Access Pipeline and CEO Profile in Media Appearance
18d ago
XELTI
Premium
Private Companies
Xeltis Highlights Leadership Recognition and Milestone Year in Medtech
23d ago
XELTI
Premium
Private Companies
Xeltis Intensifies European Conference Engagement to Support Vascular Implants Strategy
1M ago
XELTI
Premium
Private Companies
Xeltis Highlights Clinical Use of aXess Vascular Graft in Hemodialysis Access
1M ago
XELTI
Premium
Private Companies
Xeltis Marks Commercial Transition With CE Mark Approval and New Funding
2M ago
XELTI
Premium
Private Companies
Xeltis Raises €20.5 Million to Drive aXess Toward FDA Approval and European Expansion
2M ago
XELTI
Premium
Private Companies
Xeltis Secures Additional Funding to Advance aXess Toward FDA Approval
2M ago
XELTI
Premium
Private Companies
Xeltis Secures €20.5m to Accelerate U.S. Pivotal Trial and European Rollout of aXess
2M ago
XELTI
Premium
Private Companies
Xeltis – Weekly Recap
3M ago
XELTI
Premium
Private Companies
Xeltis Engages Key Vascular Access Leaders in Hemodialysis Event
3M ago
XELTI
Premium
Private Companies
Xeltis Begins European Commercial Rollout of aXess Hemodialysis Implant
3M ago
XELTI
Premium
Private Companies
Xeltis Begins European Rollout of aXess Vascular Access Implant After Pivotal Data Milestone
3M ago
XELTI
Premium
Private Companies
Xeltis – Weekly Recap
3M ago
XELTI
Premium
Private Companies
Xeltis Advances U.S. Pivotal Trial for aXess Hemodialysis Access Implant
3M ago
XELTI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
